Relating to reporting obligations for patient assistance programs for prescription drug purchases.
Summary
Requires prescription drug manufacturers to report to the Department of Consumer and Business Services the total number of consumers to which the manufacturer offered a patient assistance program who participated in the program, notwithstanding any increase in the price of the prescription drug for which the manufacturer offered the program.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2025
Last action Jun 28, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
9
Key actions
2
Committee
4
Jun 28, 2025
Lower · Passed
In committee upon adjournment.
lower
Apr 9, 2025
Committee
Motion to rerefer to Behavioral Health and Health Care carried. Rereferred.
lower
Apr 7, 2025
Lower · Passed
Recommendation: Do pass.
lower
Jan 17, 2025
Committee
Referred to Behavioral Health and Health Care.
lower
Jan 13, 2025
Introduced
First reading. Referred to Speaker's desk.
lower
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Em Levy
DDemocratic
Co
Anthony Broadman
DDemocratic
Co
Cyrus Javadi
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 3082
Scope: OR
Hi! I can help you understand HB 3082. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline